Creatv Bio's LifeTracDx® Liquid Biopsy Predicts Respons

Results to be presented at ASCO 2022 Annual Meeting in Chicago, ILROCKVILLE, Md.--(BUSINESS WIRE)--Creatv Bio, Division of Creatv MicroTech, Inc., announced today the release of an abstract featuring the results of its LifeTracDx® blood test for predicting response of metastatic breast cancer (mBC) to new lines of t...

Related Keywords

Rockville , Illinois , United States , Chicago , American , Creatv Lifetracdx , Daniell Adams , Creatv Bio , Division Of Creatv Microtech , Research Use , American Society Of Clinical Oncology , Division Of Creatv Microtech Inc , Nasdaq , Briacell Therapeutics Corp , Creatv Microtech , Clinical Oncology , Annual Meeting June , Briacell Therapeutics , Developmental Therapeutics , Molecularly Targeted Agents , Tracking Changes , Circulating Stromal Cells , Circulating Tumor Cells Predicts Responsiveness , New Line Induction , Metastatic Breast Cancer , Creatv Bio Director , Giuseppe Del Priore , Chief Medical Officer , Research Use Only , Circulating Tumor Cells , Cancer Associated Macrophage Like Cells ,